Objectives: In this retrospective multicenter study, we evaluated the safety of SARS-CoV-2
vaccination in patients harboring autoantibodies targeting neuronal surface and/or synaptic …

Introduction. Due to a similar pathomechanism, COVID-19 infection may significantly affect
the course of autoimmune diseases (AIDs). In our review, we aimed to assess the severity of …

Background Literature describing triggers of GFAP astrocytopathy (GFAP-A) is limited. We
report a case of GFAP-A in a patient with recent messenger ribonucleic acid (mRNA) severe …

Objective Autoimmune encephalitis includes a heterogeneous group of rare and complex
diseases, usually presenting with severe and disabling symptoms, such as behavioral …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has been a challenging time
for the whole world. Ever since the start of the pandemic, vaccine development has been …

Introduction Risk of adverse effects and exacerbation in autoimmune neurological
conditions (ANC) are frequently cited reasons for COVID-19 vaccine hesitancy. This study …

Background Several neurological manifestations shortly after a receipt of coronavirus
infectious disease 2019 (COVID-19) vaccine have been described in the recent case …

A few cases of multiple sclerosis (MS) onset after COVID-19 vaccination have been
reported, although the evidence is insufficient to establish causality. The aim of this study is …

Severe adverse events, including autoimmune diseases, have been noted in some
individuals following vaccination. It is still unknown whether a subset of these autoimmune …

Despite the fact that the global COVID-19 pandemic has officially ended, we continue to feel
its effects and discover new correlations between SARS-CoV-2 infection and changes in the …